The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Reading the Cancer Pathology Report

Structured interpretation of histology, grade, stage, and molecular findings for treatment planning

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Onkoloji department. Book Appointment →

What is Reading the Cancer Pathology Report?

A complete pathology report includes specimen description, gross findings, microscopic diagnosis, tumor type and subtype, grade, stage information including TNM elements, surgical margin status, lymphovascular and perineural invasion, and ancillary studies such as immunohistochemistry, flow cytometry, and molecular testing.

Tumor grade reflects differentiation and is reported as well, moderately, or poorly differentiated for many carcinomas and uses scoring systems such as Gleason for prostate, Nottingham for breast, and Fuhrman for renal cell. Grade complements stage as an independent prognostic variable and influences adjuvant therapy decisions.

Molecular findings increasingly drive therapy selection. Estrogen, progesterone, and HER2 receptors guide breast cancer therapy. EGFR, ALK, ROS1, BRAF, and PD-L1 in lung cancer and KRAS, BRAF, and microsatellite instability in colorectal cancer support targeted and immune-based regimens. Reports use synoptic templates to ensure completeness.

Symptoms

Asymptomatic patient awaiting biopsy result
Postoperative patient reviewing surgical pathology
Decision-making for adjuvant therapy
Multidisciplinary tumor board preparation
Second opinion consultation

Risk Factors

Recently diagnosed cancer of any site
Postoperative resection specimen
Recurrent disease with new biopsy
Diagnostic uncertainty requiring review
Need for molecular profiling

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • When a new pathology report is received
  • When margin or lymph node status is unclear
  • When molecular results are pending
  • When second opinion review is desired
  • When report differs from clinical impression

Treatment Methods

01
Confirm tumor type and subtype
02
Review grade with site-specific scoring
03
Check TNM stage elements
04
Assess margin status and lymph node count
05
Document lymphovascular and perineural invasion
06
Integrate immunohistochemistry and molecular results
07
Multidisciplinary tumor board discussion

Which Department to Visit?

You can visit our Onkoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Onkoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.